High Rate of Advanced Adenoma Detection in 4 Rounds of Colorectal Cancer Screening With the Fecal Immunochemical Test

Clinical Gastroenterology and Hepatology

Volumn 10, Issue 6, 2012, Pages 633-638

  Crotta, Sergio ^a   Segnan, Nereo ^b   Paganin, Simona ^a   Dagnes, Bruna ^a   Rosset, Roberto ^c   Senore, Carlo ^b  

^a Beauregard Hospital   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c General Practitioner   (Italy)

Author keywords

Colon Cancer; Diagnostic; Early Detection; FOBT

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SCREENING; CANCER STAGING; COHORT ANALYSIS; COLORECTAL ADENOMA; COLORECTAL CANCER; FOLLOW UP; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PROSPECTIVE STUDY;

ADENOMA; AGED; CLINICAL LABORATORY TECHNIQUES; COHORT STUDIES; COLORECTAL NEOPLASMS; HUMANS; IMMUNOASSAY; ITALY; MASS SCREENING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES;

EID: 84861332078     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.02.030     Document Type: Article

References (22)

1. Hewitson P., Glasziou P., Watson E., et al. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 2008, 103:1541-1549.
2. Mandel J.S., Church T.R., Bond J.H., et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000, 343:1603-1607.
3. Segnan N, Patnick J, von Karsa L, eds. European guidelines for quality assurance in colorectal cancer screening and diagnosis, 1st edition. Available at: Accessed 2010. http://ec.europa.eu/health/index_en.htm.
4. Zorzi M., Baracco S., Fedato C., et al. Screening for colorectal cancer in Italy: 2008 survey. Epidemiol Prev 2010, 34(Suppl 4):53-72.
5. Levi Z., Rozen P., Hazazi R., et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 2007, 146:244-255.
6. Guittet L., Bouvier V., Mariotte N., et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut 2007, 56:210-214.
7. van Rossum L.G., van Rijn A.F., Laheij R.J., et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008, 135:82-90.
8. Hol L., van Leerdam M.E., van Ballegooijen M., et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2010, 59:62-68.
9. Allison J.E., Sakoda L.C., Levin T.R., et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst 2007, 99:1-9.
10. Crotta S., Castiglione G., Grazzini G., et al. Feasibility study of colorectal cancer screening by immunochemical faecal occult blood testing: results in a northern Italian community. Eur J Gastroenterol Hepatol 2004, 16:33-37.
11. Castiglione G., Zappa M., Grazzini G., et al. Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer. Br J Cancer 1996, 74:141-144.
12. Zappa M., Castiglione G., Grazzini G., et al. Effect of faecal occult blood testing on colorectal mortality: results of a population-based case-control study in the district of Florence, Italy. Int J Cancer 1997, 73:208-215.
13. Faivre J., Dancourt V., Lejeune C., et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology 2004, 126:1674-1680.
14. Federici A., Giorgi Rossi P., Bartolozzi F., et al. The role of GPs in increasing compliance to colorectal cancer screening: a randomised controlled trial (Italy). Cancer Causes Control 2006, 17:45-52.
15. Steele R.J., McClements P.L., Libby G., et al. Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer. Gut 2009, 58:530-535.
16. Hardcastle J.D., Chamberlain J.O., Robinson M.H., et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996, 348:1472-1478.
17. Kronborg O., Fenger C., Olsen J., et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996, 348:1467-1471.
18. Rasmussen M., Fenger C., Kronborg O., et al. Diagnostic yield of a biennial Hemoccult II screening program compared to a once-only screening with flexible sigmoidoscopy and Hemoccult II. Scand J Gastroenterol 2003, 38:114-118.
19. Segnan N., Senore C., Andreoni B., et al. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. J Natl Cancer Inst 2005, 97:347-357. SCORE2 Working Group Italy.
20. Denis B., Ruetsch M., Strentz P., et al. Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test. Gut 2007, 56:1579-1584.
21. Blom J., Yin L., Lidén A., et al. A 9-year follow-up study of participants and nonparticipants in sigmoidoscopy screening: importance of self-selection. Cancer Epidemiol Biomarkers Prev 2008, 17:1163-1168.
22. Phillips N., Coldman A. Comparison of nonbreast cancer incidence, survival and mortality between breast screening program participants and nonparticipants. Int J Cancer 2008, 122:197-201.